Literature DB >> 17763387

Predictive value of actin-free Gc-globulin in acute liver failure.

Frank V Schiødt1, Kristian Bangert, A Obaid Shakil, Timothy McCashland, Natalie Murray, J Eileen Hay, William M Lee.   

Abstract

Serum concentrations of the actin scavenger Gc-globulin may provide prognostic information in acute liver failure (ALF). The fraction of Gc-globulin not bound to actin is postulated to represent a better marker than total Gc-globulin but has been difficult to measure. We tested a new rapid assay for actin-free Gc-globulin to determine its prognostic value when compared with the King's College Hospital (KCH) criteria in a large number of patients with ALF. A total of 252 patients with varying etiologies from the U.S. ALF Study Group registry were included; the first 178 patients constituted the learning set, and the last 74 patients served as the validation set. Actin-free Gc-globulin was determined with a commercial enzyme-linked immunosorbent assay kit. The median (range) actin-free Gc-globulin level at admission for the learning set was significantly reduced compared with controls (47 [0-183] mg/L vs. 204 [101-365] mg/L, respectively, P < 0.001). Gc-globulin levels were significantly higher in spontaneous survivors than in patients who died or were transplanted (53 [0-129] mg/L vs. 37 [0-183] mg/L, P = 0.002). A receiver operating characteristic curve analysis showed that a 40 mg/L cutoff level carried the best prognostic information, yielding positive and negative predictive values of 68% and 67%, respectively, in the validation set. The corresponding figures for the KCH criteria were 72% and 64%. A new enzyme-linked immunosorbent assay for actin-free Gc-globulin provides the same (but not optimal) prognostic information as KCH criteria in a single measurement at admission. Copyright 2007 AASLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763387     DOI: 10.1002/lt.21236

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  10 in total

Review 1.  Management and prognosis of acute liver failure in children.

Authors:  Daniel D'Agostino; Silvia Diaz; Maria Camila Sanchez; Gustavo Boldrini
Journal:  Curr Gastroenterol Rep       Date:  2012-06

2.  Liver Transplant Listing in Pediatric Acute Liver Failure: Practices and Participant Characteristics.

Authors:  James E Squires; David A Rudnick; Regina M Hardison; Simon Horslen; Vicky L Ng; Estella M Alonso; Steven H Belle; Robert H Squires
Journal:  Hepatology       Date:  2018-11-01       Impact factor: 17.425

3.  Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.

Authors:  Ai-Sheng Ho; Chun-Chia Cheng; Shui-Cheng Lee; Meng-Lun Liu; Jing-Ying Lee; Wen-Ming Wang; Chia-Chi Wang
Journal:  J Biomed Sci       Date:  2010-07-15       Impact factor: 8.410

4.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

5.  Circulating complexes of the vitamin D binding protein with G-actin induce lung inflammation by targeting endothelial cells.

Authors:  Lingyin Ge; Glenda Trujillo; Edmund J Miller; Richard R Kew
Journal:  Immunobiology       Date:  2013-10-14       Impact factor: 3.144

Review 6.  Liver transplantation in acute liver failure: A challenging scenario.

Authors:  Manuel Mendizabal; Marcelo Oscar Silva
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure.

Authors:  David A Rudnick; Dennis J Dietzen; Yumirle P Turmelle; Ross Shepherd; Song Zhang; Steven H Belle; Rob Squires
Journal:  Pediatr Transplant       Date:  2008-07-17

8.  Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.

Authors:  Zeyu Sun; Xiaoli Liu; Daxian Wu; Hainv Gao; Jing Jiang; Ying Yang; Jie Wu; Qikang Gao; Jie Wang; Zhengyi Jiang; Youping Xu; Xiao Xu; Lanjuan Li
Journal:  Theranostics       Date:  2019-01-30       Impact factor: 11.556

9.  Mass Spectrometry-Based Proteomics Reveal Alcohol Dehydrogenase 1B as a Blood Biomarker Candidate to Monitor Acetaminophen-Induced Liver Injury.

Authors:  Floriane Pailleux; Pauline Maes; Michel Jaquinod; Justine Barthelon; Marion Darnaud; Claire Lacoste; Yves Vandenbrouck; Benoît Gilquin; Mathilde Louwagie; Anne-Marie Hesse; Alexandra Kraut; Jérôme Garin; Vincent Leroy; Jean-Pierre Zarski; Christophe Bruley; Yohann Couté; Didier Samuel; Philippe Ichai; Jamila Faivre; Virginie Brun
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

10.  Plasma Actin-free Gc-globulin in Patients with Chronic or Acute-on-chronic Liver Failure Caused by Hepatitis B Virus.

Authors:  Huan Liu; Tao Han; Shi Xiang Xiao; Jun Li; Jun Lee; Yan Li; Zheng Yan Zhu; You Qing Xu
Journal:  Gastroenterology Res       Date:  2009-07-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.